Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st
29. Juli 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models
22. Juli 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator
08. Juli 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference
03. Juli 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)
20. Juni 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology Association
14. Juni 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at Jefferies Global Healthcare Conference
29. Mai 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
14. Mai 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Reports 2013 First Quarter Financial Results
29. April 2013 16:00 ET
|
Astex Pharmaceuticals, Inc.
Data reported at AACR on several preclinical and clinical programs
Ends quarter with $137 million in cash & marketable securities
First quarter royalty revenue increases 7.3% to $22.1...
Astex Pharmaceuticals to Present at Needham Healthcare Conference
23. April 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...